Peritassine A is primarily investigated for its potential neuroprotective properties, showing promise in early research related to neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. It has demonstrated the ability to modulate specific neuronal signaling pathways, which may help in reducing neuronal damage caused by oxidative stress and inflammation. Additionally, Peritassine A exhibits affinity for certain central nervous system receptors, making it a candidate for further study in mood regulation and cognitive enhancement. Due to its natural origin and observed low toxicity in preliminary studies, it is also being explored as a lead compound for developing novel therapeutics with fewer side effects. Current applications remain in the preclinical research phase, mainly in cellular and animal models.